Table 2.
Variable | Survived N (%) | Died N (%) | P-Value |
---|---|---|---|
Overall Survival | 1226 (45.0) | 1501 (55.0) | <0.01 |
| |||
Sociodemographic: | |||
Male | 1203 (44.1) | 1484 (54.4) | 0.1 |
Age Group: | |||
<60 years | 550 (20.2) | 579 (21.2) | <0.01 |
60–70 years | 471 (17.3) | 647 (23.7) | 0.01 |
70–80 years | 97 (3.6) | 141 (5.2) | 0.17 |
80–90 years | 2 (0.07) | 3 (0.11) | 0.82 |
90–100 years | 1 (0.04) | 1 (0.04) | 0.88 |
Race: | |||
White | 942 (34.5) | 1115 (40.9) | 0.12 |
Black | 228 (8.4) | 307 (11.3) | 0.23 |
Hispanic | 83 (3.0) | 115 (4.2) | 0.37 |
Other | 56 (2.1) | 79 (2.9) | 0.41 |
Married | 642 (23.5) | 742 (27.2) | 0.13 |
Smoking Cessation | 383 (14.0) | 422 (15.5) | 0.08 |
Alcohol Abuse | 51 (1.9) | 68 (2.5) | 0.64 |
Drug Abuse | 17 (0.62) | 15 (0.55) | 0.35 |
VA Priority Group: | |||
1 | 205 (7.5) | 264 (9.7) | 0.55 |
2–6 | 898 (32.9) | 1124 (41.2) | 0.33 |
7–8 | 120 (4.4) | 112 (4.1) | 0.03 |
Comorbid Conditions: | |||
Myocardial Infarction | 104 (3.8) | 158 (5.8) | 0.07 |
Congestive Heart Failure | 253 (9.3) | 460 (16.9) | <0.01 |
Peripheral Vascular Disease | 210 (7.7) | 332 (12.2) | <0.01 |
COPD | 324 (11.9) | 471 (17.3) | <0.01 |
Rheumatic Fever | 35 (1.3) | 40 (1.5) | 0.76 |
Cirrhosis | 12 (0.44) | 27 (0.99) | 0.07 |
Dementia | 35 (1.3) | 76 (2.8) | <0.01 |
Diabetes (without complications) | 533 (19.5) | 657 (24.1) | 0.88 |
Diabetes (with complications) | 192 (7.0) | 293 (10.7) | <0.01 |
Hepatitis | 6 (0.22) | 13 (0.48) | 0.24 |
Paraplegia | 33 (1.2) | 52 (1.9) | 0.25 |
Renal Disease | 319 (11.7) | 450 (16.5) | 0.02 |
Cancer | 283 (10.4) | 410 (15.0) | 0.01 |
Metastatic Cancer | 42 (1.5) | 85 (3.1) | <0.01 |
AIDS | 4 (0.15) | 7 (0.26) | 0.56 |
Number of Medications by type:* | |||
Diabetes | .43 (.02) | .41 (.02) | 0.28 |
Pulmonary | .50 (.04) | .63 (.04) | 0.99 |
Cardiac | 1.9 (.05) | 1.8 (.05) | 0.04 |
Oral | .26 (.02) | .26 (.02) | 0.50 |
Table shows outcomes as total number and percentage or mean and standard deviation
Includes medications given 90 days prior to admission.